Recurrent gliomas

References

• Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005; 64:479 - 89; PMID: 15977639
   PubMed Web of Science ®Google Scholar
• DeAngelis LM. Brain tumors. N Engl J Med 2001; 344:114 - 23; http://dx.doi.org/10.1056/NEJM200101113440207; PMID: 11150363
   PubMed Web of Science ®Google Scholar
• Mitchell P, Ellison DW, Mendelow AD. Surgery for malignant gliomas: mechanistic reasoning and slippery statistics. Lancet Neurol 2005; 4:413 - 22; http://dx.doi.org/10.1016/S1474-4422(05)70118-6; PMID: 15963444
   PubMed Web of Science ®Google Scholar
• Burton EC, Prados MD. Malignant gliomas. Curr Treat Options Oncol 2000; 1:459 - 68; http://dx.doi.org/10.1007/s11864-000-0073-2; PMID: 12057153
   PubMedGoogle Scholar
• Carapella CM, Telera S, Oppido PA. Surgery of malignant gliomas: advances and perspectives. Curr Opin Oncol 2011; 23:624 - 9; http://dx.doi.org/10.1097/CCO.0b013e32834ace58; PMID: 21857513
   PubMed Web of Science ®Google Scholar
• Ikushima H. Radiation therapy: state of the art and the future. J Med Invest 2010; 57:1 - 11; http://dx.doi.org/10.2152/jmi.57.1; PMID: 20299738
   PubMedGoogle Scholar
• Darakchiev BJ, Albright RE, Breneman JC, Warnick RE. Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme. J Neurosurg 2008; 108:236 - 42; http://dx.doi.org/10.3171/JNS/2008/108/2/0236; PMID: 18240917
   PubMed Web of Science ®Google Scholar
• Langley SE, Laing RW. Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer. Prostate Cancer Prostatic Dis 2004; 7:201 - 7; http://dx.doi.org/10.1038/sj.pcan.4500727; PMID: 15184864
   PubMed Web of Science ®Google Scholar
• Zhang FJ, Li CX, Zhang L, Wu PH, Jiao DC, Duan GF. Short- to mid-term evaluation of CT-guided 125I brachytherapy on intra-hepatic recurrent tumors and/or extra-hepatic metastases after liver transplantation for hepatocellular carcinoma. Cancer Biol Ther 2009; 8:585 - 90; http://dx.doi.org/10.4161/cbt.8.7.7902; PMID: 19276683
   PubMed Web of Science ®Google Scholar
• Tanderup K, Georg D, Pötter R, Kirisits C, Grau C, Lindegaard JC. Adaptive management of cervical cancer radiotherapy. Semin Radiat Oncol 2010; 20:121 - 9; http://dx.doi.org/10.1016/j.semradonc.2009.11.006; PMID: 20219550
   PubMed Web of Science ®Google Scholar
• Mayadev J, Merrick GS, Reed JR, Butler WM, Galbreath RW, Allen ZA, et al. Permanent prostate brachytherapy in prostate glands <20 cm(3). Int J Radiat Oncol Biol Phys 2010; 76:1450 - 5; http://dx.doi.org/10.1016/j.ijrobp.2009.04.014; PMID: 20338476
   PubMed Web of Science ®Google Scholar
• Sakurai H, Mitsuhashi N, Harashima K, Muramatsu H, Ishikawa H, Kitamoto Y, et al. CT-fluoroscopy guided interstitial brachytherapy with image-based treatment planning for unresectable locally recurrent rectal carcinoma. Brachytherapy 2004; 3:222 - 30; http://dx.doi.org/10.1016/j.brachy.2004.09.007; PMID: 15607154
   PubMedGoogle Scholar
• Van Limbergen E, Weltens C. New trends in radiotherapy for breast cancer. Curr Opin Oncol 2006; 18:555 - 62; http://dx.doi.org/10.1097/01.cco.0000245327.42281.9f; PMID: 16988575
   PubMed Web of Science ®Google Scholar
• Liu BL, Cheng JX, Zhang X, Zhang W. Controversies concerning the application of brachytherapy in central nervous system tumors. J Cancer Res Clin Oncol 2010; 136:173 - 85; http://dx.doi.org/10.1007/s00432-009-0741-y; PMID: 19956971
   PubMed Web of Science ®Google Scholar
• Ling CC. Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model. Int J Radiat Oncol Biol Phys 1992; 23:81 - 7; http://dx.doi.org/10.1016/0360-3016(92)90546-T; PMID: 1572833
   PubMed Web of Science ®Google Scholar
• Zhang FJ, Li CX, Jiao DC, Zhang NH, Wu PH, Duan GF, et al. CT guided 125iodine seed implantation for portal vein tumor thrombus in primary hepatocellular carcinoma. Chin Med J (Engl) 2008; 121:2410 - 4; PMID: 19102958
   PubMed Web of Science ®Google Scholar
• Laperriere NJ, Leung PM, McKenzie S, Milosevic M, Wong S, Glen J, et al. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 1998; 41:1005 - 11; http://dx.doi.org/10.1016/S0360-3016(98)00159-X; PMID: 9719109
   PubMed Web of Science ®Google Scholar
• Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, et al. High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 1992; 24:583 - 91; http://dx.doi.org/10.1016/0360-3016(92)90702-J; PMID: 1429079
   PubMed Web of Science ®Google Scholar
• Chamberlain MC, Barba D, Kormanik P, Berson AM, Saunders WM, Shea MC. Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumors. Arch Neurol 1995; 52:162 - 7; http://dx.doi.org/10.1001/archneur.1995.00540260066018; PMID: 7848125
   PubMed Web of Science ®Google Scholar
• Selker RG, Shapiro WR, Burger P, Blackwood MS, Arena VC, Gilder JC, et al, Brain Tumor Cooperative Group. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 2002; 51:343 - 55, discussion 355-7; PMID: 12182772
   PubMed Web of Science ®Google Scholar
• Nieder C, Andratschke N, Wiedenmann N, Busch R, Grosu AL, Molls M. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?. Strahlenther Onkol 2004; 180:401 - 7; PMID: 15241527
   PubMedGoogle Scholar
• Fink J, Born D, Chamberlain MC. Pseudoprogression: relevance with respect to treatment of high-grade gliomas. Curr Treat Options Oncol 2011; 12:240 - 52; http://dx.doi.org/10.1007/s11864-011-0157-1; PMID: 21594589
   PubMed Web of Science ®Google Scholar
• Hygino da Cruz LC Jr., Rodriguez I, Domingues RC, Gasparetto EL, Sorensen AG. Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 2011; 32:1978 - 85; http://dx.doi.org/10.3174/ajnr.A2397; PMID: 21393407
   PubMed Web of Science ®Google Scholar
• McDermott MW, Sneed PK, Gutin PH. Interstitial brachytherapy for malignant brain tumors. Semin Surg Oncol 1998; 14:79 - 87; http://dx.doi.org/10.1002/(SICI)1098-2388(199801/02)14:1<79::AID-SSU10>3.0.CO;2-4; PMID: 9407634
   PubMed Web of Science ®Google Scholar
• Halligan JB, Stelzer KJ, Rostomily RC, Spence AM, Griffin TW, Berger MS. Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas. Int J Radiat Oncol Biol Phys 1996; 35:541 - 7; http://dx.doi.org/10.1016/S0360-3016(96)80017-4; PMID: 8655378
   PubMed Web of Science ®Google Scholar
• Zamorano L, Li Q, Tekyi-Mensah S, Gaspar L, Fontanesi J, Levin K. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas. Stereotact Funct Neurosurg 2003; 81:10 - 7; http://dx.doi.org/10.1159/000075098; PMID: 14742958
   PubMed Web of Science ®Google Scholar
• Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 1999; 17:2572 - 8; PMID: 10561324
   PubMed Web of Science ®Google Scholar
• Gilbert MR, Friedman HS, Kuttesch JF, Prados MD, Olson JJ, Reaman GH, et al. A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. Neuro Oncol 2002; 4:261 - 7; PMID: 12356356
   PubMed Web of Science ®Google Scholar
• Zhu T, Zhao Y, Zhang J, Li L, Zou L, Yao Y, et al. ß-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6. Int J Oncol 2011; 38:419 - 26; PMID: 21132268
   PubMed Web of Science ®Google Scholar
• Wu XS, Xie T, Lin J, Fan HZ, Huang-Fu HJ, Ni LF, et al. An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas. J Pharm Pharmacol 2009; 61:1653 - 6; http://dx.doi.org/10.1211/jpp.61.12.0010; PMID: 19958588
   PubMed Web of Science ®Google Scholar